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Iron·Ligand in Hemerythrin.

APPROVED BY MEMBERS OF THE THESIS COMMITTEE:

nn S. Loehr, Chairperson

The amino acid sequence determination of Phascolopsis gouldii
hemerythrin in the region of the proposed iron ligand at position 58
was the main objective of this research endeavor. Generation of a large
peptide was pursued by trypsin digestion of citraconylated hemerythrin
producing peptide 50-113 for sequenator analysis.

Detection of the

phenylthiohydantoin amino acid derivatives by gas-liquid and high-performance-liquid chromatography yielded unambiguous sequence elucidation
through the region of interest identifying residue 58 as glutamic acid.
Further specific digestion of peptide 50-113 by cyanogen bromide
yielded peptides 50-62 and 63-113 which were chromatographically resolved

using Sephadex G-50 superfine. The identity of peptide 50-62 was verified
by amino acid analysis.

Sequenator analysis of this peptide substantiated

the assignment of residue 58 as glutamic acid.
Attempts to sequence peptide 54-74, derived from trypsin digestion
of peptide 50-113, were frustrated in the ion exchange purification step.
The peptide's high percentage of hydrophobic residues as well as its
isoelectric form in the polar pyridine-acetate pH 5.0 buffer resulted in
peptide insolubility.
Identification of residue 58 as glutamic acid in Phascolopsis
gouldii hemerythrin is significant in the.support it lends to the proposed
model of the iron active site of Themiste dyscritum hemerythrin.
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INTRODUCTION
Hemerythrin and myohemerythrin are non-heme iron proteins whose
function is reversible oxygen binding.

Invertebrate marine worms of the

sipunculid phylum contain hemerythrin in their coelomic fluid and
myohemerythrin in their muscle cells.

Hemerythrin of the Atlantic coastal

Phascolopsis (syn. Golfingia) gouldii is tje protein under investigation
in this study.

The protein is an octamer of molecular weight 108,000

containing two iron atoms per monomer (1).

IDENTIFICATION OF IRON LIGANDS
The x-ray crystal structure of

c

r_. gouldii hemerythrin at 5.5 A

resolution indicates that the two irons in each monomer are in close
proximity and are coordinated by amino acid side chains from four, approximately parallel helices which comprise 70% of the protein structure (2).
0

A 2.8 A resolution crystal structure has been obtained for coelomic
hemerythrin from a sipunculid indigenious to the Pacific coastal waters,
Themiste (syn. Dendrostomum) dyscritum (3). The two iron atoms in the
metaquo form of the T. dyscritum protein are in a trigonal antiprism with
each iron octahedrally coordinated to five protein ligands (Fig. 1).
Two of the ligands are common to both iron atoms and a third shared coordination site contains a water molecule which is presumably replaced by
oxygen in the native form of the protein. The iron binding site in

f.. gouldii hemerythrin is very likely identical to that in I.· dyscritum
hemerythrin as the two proteins exhibit similar spectroscopic properties
(4) as well as similar protein conformations.
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Figure 1. Proposed model for0 the active site pf metaquo T.
dyscritum hemerythrin at 2.8 A resolution (3). The same Tron
ligands have been identified for myohemerythrin but with
differing numbering (30). In the oxy form, the water is
presumably replaced by 02 which is bound as the peroxide,

02 (31).
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The 2.8 A resolution electron density map of l· dyscritum
hemerythrin in conjunction with the protein's amino acid sequence (5)
identified the iron ligands as His-25, His-54, Glu-58, His-74, His-77,
His-101, Asp-106, and Tyr-109. These data were corroborated by the x-ray
diffraction studies (6) and amino acid sequence (7) of myohemerythrin from

l· zostericolum, another Pacific Coast sipunculid (formerly misidentified
as T. pYroides).

The amino acid sequence off_. gouldii hemerythrin (8)

showed that seven of the amino acid ligand identities coincided.

However,

in the eighth ligand assignment, the sequences of T. dyscritum hemerythrin
and T. zostericolum myohemerythrin indicated a glutamic acid at position
58 while residue 58 off_. gouldii hemerythrin was identified as glutamine.
The apparent lack of conservation of an iron ligand seemed unlikely and
prompted the present investigation.
This study was undertaken to more accurately determine the identity
of the amino acid at position 58 in f_. gouldii hemerythrin.

If glutamic

acid proved to be the correct amino acid at residue 58, this would lend
support to the trigonal antiprism model in which glutamic acid acts as
one of the bridging ligands.

However, should glutamine be verified as

the amino acid at position 58, it would be the first example of glutamine
as a metal ligand.

It is known that amides have a low basicity and are,

therefore, poor metal ligands (32).

An active iron center containing

an inferior ligand most probably would be disgarded by natural selection.
The ~-carboxyl group of glutamic acid, however, is deprotonated above
pH 4.2.

Thus, there is a sound chemical basis for predicting glutamic

acid as the correct iron ligand.

AMINO ACID SEQUENCE DETERMINATION
Facile elucidation of an amino acid sequence is attributable to
the innovative automated protein sequenator of Edman and Begg (9).
Utilization of the sequenator allows derivatization, cleavage and isolation of amino acids sequentially from a peptide's NH 2-terminus. The
method emphasizes generation of a few large peptides from the parent
protein instead of the many small peptides previously required for the
manua) Edman degradation procedure.

The requirement of few large

peptides necessitates availability of highly specific cleavage agents
or suitable blocking groups to hone an agent's specificity.
Trypsin is an endopeptidase specific for cleavage at the COOHterminus of lysine and arginine.

The enzyme's mode of action is illus-

trated in the following reaGtion:

+ H+3N-R· · ·z-coo -

Trypsin is often contaminated with chymotrypsin, an enzyme that cleaves
at the COOH-terminus of aromatic residues.

Thus, trypsin preparations

generally contain an inhibitor of chymotrypsin such as L-(tosyl-2-phenyl)
chloroethyl methyl ketone (TPCK) to ensure an enzyme preparation of
reliable specificity.
For trypsin digestion it is beneficial to block cysteine residues
since the presence of an acidic residue adjacent to arginine or lysine
reduce~

the effective cleavage (10).

Furthermore, blocking cysteine

residues prevents oxidation of sulfhydryl groups to intra- or inter-
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molecular disulfide moities which yield anomalous sequences. A blocking
method of choice is represented by the reaction of 4-vinyl pyridine with
a cysteinyl residue (11):

I
r=O

-0

cr-CH 2-SH+CH 2=CH

~

I

C=O

C~-CH 2-S-CH 2 -cH 2~N

;}N

NH

NH
I

IPYRIDYLETHYL CYSTEINE

CYSTEINE 4-VINYL PYRIDINE

The protein subunit is reduced with dithiothreitol prior to reaction with
4-vinyl pyridine since derivatization occurs only with the sulfhydryl
form of cysteine.

In the subsequent amino acid compos.ition

a~d

sequence

determination, cysteine is detected as pyridylethyl cysteine.
Derivatization of the E-amino group of lysine confers enhanced
specificity on trypsin, such that it only cleaves after arginine.
Citraconic anhydride is a blocking agent of choice due to the high
solubility of its protein derivative at neutral pH and the ease of
removal of the blocking group in acid.

Lysine reacts with citraconic

I
C=O
I

0
II

CH

I 3

---=>~ CHfCH 2 t 4NH-C-CH=C-C00-+2H+

I

0

CITRACONIC
ANHYDRIDE

NH

I CITRACONYL PEPTIDE

Other lysine blocking groups such as succinic anhydride and trifluoroacetic acid are less useful due to the difficulty of removal of the
blocking group and solubility of the protein derivative, respectively (12).

. 6

Cyanogen bromide is known to specifically cleave the COOHterminal bond of methionine (13):
~

I

···CO-NH-CH-C-N-CHR ··· + Br-C:N

)

8

"

CH 2-S-CH 3

CH 2

>

Br

METHIONINE

CYANOGEN
BROMIDE

CYANOSULFONIUM INTERMEDIATE (I)
+ Br-

·· ·CO-N-CH-C=NH-CHR ···+CH -SCN
'0
3
CH/ 2
1

~CH/
2

Br
CYANOSULFONIUM INTERMEDIATE (I)
· · ·CO- ~ -CH-C=NH-CHR '·. ·
+ Br-

/""'

\

CH 2

~CH/

H0

2

. . . . ._
--~-";;:7'~

0

2

IMINOLACTONE (II)

IMINOLACTONE (II) METHYL THIOCYANATE

H
+
···CO-N-CH-C=O + H N-CHR
/

CH 2

\

3

1
•••

/

~H2

PEPTIDYL HOMOSERINE LACTONE (III)

The starting material is first reduced to convert any methionine sulfone
or sulfoxide to methionine (14).

Upon addition of CNBr, an unstable

cyanosulfonium intermediate forms and then converts to the iminolactone
(II) with elimination of the methyl thiocyanate as by-product.

Hydrolysis

of compound II produces the aminoacyl peptide and the peptidyl homoserine
lactone.

I
I
I.

I

Once specific peptides are isolated and purified, degradation
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from the NH 2-terminal is performed automatically in the sequenator
designed by Edman and Begg (9). The method involves the following
reaction scheme:

COUPLING STEP

PHENYLISOTHIOCYANATE

PHENYLTHIOCARBAMYL (PTC) PEPTIED (I)

CYCLIZATION STEP

PTC-PEPTIDE

ANILINO-THIAZOLINONE
DERIVATIVE (II)

REARRANGEMENT STEP

c6H5-NHC-S
II
I

N C=O
\ I
CH
I
Rl

ANILINO-THIAZOLINONE
DERIVATIVE (II)

PHENYLTHIOHYDANTOIN (PTH)
DERIVATIVE (II I)

The initial step involves formation of the phenyl thiocarbamyl derivative
(I) which subsequently forms the thiazolinone (II) and peptide with a new

8

NH 2-terminal.

Once (II) is removed by extraction, the peptide is ready

for another round of coupling and cyclization. The extracted compound
(II) is slowly rearranged to the more stable PTH-amino acid (III) in
an acid-catalyzed reaction.

The resulting PTH amino acids are detected

by gas-liquid and high-performance-liquid chromatography. These
dete£tion methods offer greater sensitivity and accuracy than was previously possible with paper electrophoresis, thin-layer chromatography
or amino acid analyzers.
The methods outlined above, in conjunction with gel permeation
and ion exchange chromatography, were used to produce peptides of
purity suitable for unambiguous determination of the sequence in the
region of residue 58 in .!:· gouldii hemerythrin.

EXPERIMENTAL PROCEDURES
PREPARATION OF HEMERYTHRIN
The sipunculid worm, Phascolopsis gouldii, was obtained from
the Marine Biological Station in Woods Hole, Massachusetts.

Erythrocytes,

which contain hemerythrin, were separated from coelomic hemolymph,
purified and lysed (15).

Hemerythrin crystallization was effected by

dialysis at 4oc against a 100-fold excess of 20% ethanol, 0.01 M sodium
azide and 0.01 MTris-Cl (tris hydroxymethyl-aminomethane) pH 7.5.
Conversion of hemerythrin to the iron-free apo form was accomplished
by the method of Loehr, et al. (5).

CHEMICAL MODIFICATION OF HEMERYTHRIN

f

Apohemerythrin was reacted with 4-vinyl _pyridine to covalently
block cysteine and thus, stabilize the residue to oxidation (11).
The hemerythrin modification procedure involved reduction of protein
subunits which contain 3.7 µmoles cysteine with 0.12 mmole dithiothreitol,
followed by reaction with 0.36 mmole 4-vinyl pyridine.

Pyridylethylated

hemerythrin and peptiaes were used in all subsequent reactions.

The

reaction was monitored by the presence of an absorbance maximum at 260 nm
due to pyridylethly cysteine (16).
Pyridylethylated hemerythrin was further modified to prevent
trypsin digestion at lysyl residues by reaction with citraconic
anhydride.

Approximately 3.7 µmole of hemerythrin subunits containing

\

~-··· . .- ·

1•"Wlll-l•-11-1--•111•11•1J•-
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41 µmole lysine (17) were covalently blocked with 1.9 rrmole citraconic
anhydride was vacuum distilled at 75oc and 2.5 mm Hg.

Alkaline con-

ditions were maintained throughout the reaction and dialysis, as the
citraconyl-lysyl bond is acid labile.

SPECIFIC CLEAVAGE OF HEMERYTHRIN
Citraconylated pyridylethylated hemerythrin was digested specifically
at the COOH-terminus of arginyl residues by TPCK-trypsin (5). The
reaction mixture contained 3 mg trypsin per 100 mg hemerythrin.

The

reaction temperature was maintained at 37oc by a Lauda circulator.
Following the digestion, the solution was acidified to pH 1.5 with 88%
formic acid to hydrolyze the citraconyl-lysyl bonds. The protein
solution was shelled in dry'ice-acetone and lyophilized using a Virtis,
Model 10-020. The lyophilized protein was dissolved by wetting with
glacial acetic acid, followed by dilution with distilled water to
approximately 10% acetic acid.

The tryptic peptides were separated

on Sephadex G-50 superfine in 9% formic acid by gel permeation chromategraphy.
One of the tryptic peptides (peptide 50-113) was treated with
cyanogen bromide to obtain specific cleavage at the COOH-terminus of
the methionyl residue (13).

Approximately 1.0 meq cyanogen bromide

was reacted with 1.8 µeq methionyl residue in the peptide in 70% formic
acid for 24 hours.

Following the reaction, the material was lyophilized

and peptides were separated by gel permeation on Sephadex G-50 superfine
in 9% formic acid.

The sample on which amino acid composition was

determined was subjected to reduction with 30% mercaptoethanol prior to

l

I
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CNBr cleavage (-14}. The reduced protein solution was dialyzed against
increasing concentrations of formic acid (10%, 20%, 70%) to remove
excess mercaptoethanol and 5 Mguanidine hydrochloride. The sample on
which sequenator analysis was performed was not subjected to reduction
prior to CNBr cleavage.
Peptide 50-113 was also subjected to a second TPCK-trypsin digest
(3 mg trypsin per 50 mg peptide) without prior citraconylation to obtain
proteolysis at the COOH-terminus of lysyl residues.

In the preliminary

runs, the tryptic hydrolysate was immediately shelled and lyophilized.
Poor dissolution of the lyophilized protein in the chromatographic
solvent prompted dialysis against 9% formic acid instead of lyophilization in later runs.

The major tryptic peptide from this digestion

(peptide 54-74) was purified by successive passage through columns of
Sephadex G-50 and G-25 superfine and Bio-Rad AG 50W-X2.
SPECTROPHOTOMETRIC ANALYSES
All spectrophotometric analyses were made using a Cary 14
spectrophotometer.
length were used.

Matched 1 ml quartz curvettes with a 1 cm path
The reference cell contained 9% formic acid.

Absorbances at 280 nm were used to determine protein concentrations
and resolve chromatographic fractions at certain key stages of the
sequence determination.

The following extinction coefficients were used:

apohemerythrin and pyridylethyl hemerythrin, E280 = 2.0 ml/mg; peptide
50-113, E280 = 2.5 ml/mg; peptide 54-74, E280 = 0.8 ml/mg; peptide 50-62,
E280 = 0.3 ml/mg, E260 = 3.3 ml/mg. These values were calculated from
the known composition of tyrosine, tryptophan and pyridylethyl cysteine

1
12
per 13,500 molecular weight subunit (18).

Ultraviolet spectra were

used to identify products from the characteristic absorbance profiles
of tyrosine, tryptophan and pyridylethylcysteine.
CHROMATOGRAPHY
Gel permeation chromatography was performed in glass columns,
Pharmacia (1.5 x 86 cm) and Kontes Chromaflex (2.5 x 86 cm).

The

used were Sephadex G-25 and G-50, superfine grades, purchased

mat~ices

from Pharmacia and Sigma. The equilibrium and eluant solvent was 9%
formic acid.

Products were generally detected by their absorbances at

280 nm, although peptide 50-62 was detected by its absorbance at 260 nm.
Ion exchange chromatography was used to purify tryptic peptide
54-74 prior to amino acid analysis. The column diameter was 0.6 cm.
The height of the Bio-Rad AG 50W-X2 resin bed was 56 cm. The column
temperature was maintained at 47oc.

A continuous pH gradient (3.1 to

5.0) effected column elution. This procedure was done using the method
and equipment developed by Jones (19).

Ion exchange fractions were

resolved by reaction with ninhydrin (20) and absorbance at 570 nm of the
Ruhemann s purple complexes.
1

AMINO ACID ANALYSIS
Amino acid analyses (21) were performed on the tryptic peptide
54-74 and cyanogen bromide peptide

50~62.

Each peptide was hydrolyzed

under vacuum in 6 N HCl at llo 0 c for 24 hours. The amino acid hydrolysates
were evaporated to dryness and dissolved in 3.0 ml buffer.

Separation

and detection of the amino acids were done using a Beckman amino acid

13

analyzer, Model 120C.

Methionine of the CNBr peptide was detected as

homoserine lactone since the equilibrium between homoserine and the
lactone is shifted to the lactone on heating in acid.

Cysteine was

detected as the pyridylethylated derivative.
AMINO ACID SEQUENCE DETERMINATION
Amino acid sequences were determined for tryptic peptide 50-113
and CNBr peptide 50-62 using an automated Edman degradation procedure
and a Beckman Sequencer, Model 890 as described previously (9), but
modified to improve yields from peptides (22).

Sequenator products

were identified by gas chromatography, thin layer chromatography, and
spot tests, as described previously (22) and by high-performance liquid
chromatography (Bio-Analytical Systems, Inc.) as described by Zimmerman,
et al. (23).

1

RESULTS
The amino acid at position 58 in f_. gouldii hemerythrin was identified as glutamic acid using specific peptide cleavage techniques in conjunction with amino acid analysis and automated Edman sequence determination.

Tryptic hydrolysis of citraconylated pyridylethylated hemerythrin

yielded three peptides (Fig. 2) as observed previously (12).

These peptides

were identified as 50-113, 16-48 and 1-15 in order of decreasing molecular
weight (12).

Since the amino acid composition and manual sequence

information have already been reported for peptide 50-113 (12), this
peptide was subjected only to sequenator analysis.
50-113 are summarized in Table I.

The data for peptide

Further digestions of peptide 50-113

and the resulting peptides are shown in Figure 3. Cyanogen bromide
cleavage yielded peptide 50-62 which was identified by amino acid analysis
(Table II) and utilized for sequence determination (Table I).

Trypsin

digestion of pyridylethylated 50-113 produced peptide 54-74 which was
characterized by amino acid analysis (Table II), but was not available
in sufficient quantity or purity for sequenator analysis.
PEPTIDE 50-113
Peptide 50-113 was isolated by Sephadex chromatography of the
tryptic hydrolysate of citraconylated pyridylethylated hemerythrin.

The

elution pattern (Fig. 2) appears identical to that reported previously (12)
and fractions from the earliest elution peak 0.45 VT (peptide 50-113)
were pooled, lyophilized and used for sequenator analysis.

The peptide

15

0,45

3.0

~

2.0

~

1.0

PEPTIDE ~ill

70

llO

Figure 2. Gel permeation chromatography of trypsin digestion
products of citraconylated hemerythrin on Sephadex G-50 superfine .
.A 50 mg sample was applied to the column (1.5 x 86 cm) and
eluted with 9% formic acid at a flow rate of B ml/hr. Fractions
were pooled as indicated by horizontal line. Numbers above each
peak refer to the fraction of the total column volume (Vt) at
which the material is eluting. Peptide designations are based

on previous identification (12).
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TABLE I
SEQUENATOR ANALYSES OF HEMERYTHRIN FRAGMENTSa
POSITION
PTH

PEPTIDE 50-113
PEPTIDE 50-62
DERIVATIVE DETECTIONb PTH DERIVATIVE DETECTIONb
T
G
G
G

7

CVS
THR
GLY
LYS
. HIS
PHE
Lt:U

8

ASN

G

9

GLU
GLN
VAL
LEU
MET

G
G
G
G
G

1
2
3

4
5
6

10
11

12
13

s
G
G

CYS,ARG
THR
GLY
LYS
HIS
PHE
LEU
ASN·
GLU
GLN
VAL
LEU

H
G,H
G,H
G,H
H

G,H
G,H
G~H

G,H
G,H
H

H

aAt any given position, all amino acids which were unambiguously
identified are reported, with the exception of amino acids carried
over from previous steps. Repetitive step-wise yields were 94-97%
based on quantitation of gas chromatography data.

bG =gas chromatography (22), H =high-performance-liquid chromatography (23), S =spot test (22), T =thin layer chromatography (22).

17

10
20
GLY-PHE-PRO-ILE-PRO-ASP-PRO-TYR-VAL-TRP-ASP-PRO-SER-PHE-ARG-TI-R-PHE-TYR-SER-ILE-

30

~o

50

60

ILE-ASP-ASP-GLU-HIS-LYS-~-LEU-PHE-ASN-GLY-ILE-PHE-HIS-LEU-ALA-ILE-ASP-ASP-ASN-

AlJ>.-ASP-ASN-LEU-GLY-GLU-LEU-ARG-ARG-CYS-THR-GLY-LYS-HIS-PHE-LEU-ASN-GLU-GLN-VAL-

-----------1H I...

. . ... ... ... ... ... ... ... ... ...
.---~

70

+

+

--------- -+

...................

....

80

LEU-MET-GLN-ALA-SER-GLN-TYR-GLN-PHE-TYR-ASP-GLU-HIS-LYS-LYS-GLU-HIS-GLU-GLY-PHE+

....

~~r----------------90
100

ILE-HIS-ALA-LEU-ASP-ASN-TRP-LYS-GLY-ASP-VAL-LYS-TRP-ALA-LYS-SER-TRP-LEU-VAL-ASN-

-------------~----~----

llO

.......

--

HIS-ILE-LYS-Tl-R-ILE-ASP-PHE-LYS-TYR-LYS-GLY-LYS-ILE

--------------1
Figure 3. The amino acid sequence off.. gouldii hemerythrin
as determined by Subramanian, et al. (8) with a change in the
identification of residues 58 and 59. Peptides were produced
by specific cleavage of citraconylated hemerythrin with
trypsin (~),and peptide 50-113 with CNBr (---). Arrows
indicate region sequ.enced by automated Edman degradations.
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TABLE II
AMINO ACID COMPOSITION OF FRAGMENTS GENERATED
BY TRYPSIN AND CYANOGEN BROMIDE DIGESTION
OF HEMERYTHRINa
AMINO
ACID

PEPTIDE 54-74
GEL PERMEATIONb

LYS
HIS

cysd(b)

ARG
ASP+ASN
THR
SER
GLU+GLN
GLY
ALA
VAL
METf(c)
ILE
LEU
TYR
PHE
TOTAL

1.6
2.0
e
e
2.0
0.5
1.8
4.4
1.4

(1)

(2)

ION EXCHANGEc
2.0 (1)
2.2 (2)
e

(2)

(0)
(1)
(6)

(0)

e
2.2 (2)
0.4 (0)
1.1 (1)

5.2 (6)
0.9 (0)

1.3 (1)

1.0 (1)

(1)

1.5 (2)

0.9 (1)
0.9 (1)
0.3 (0)
1.8 (2)
1.8 (2)
2.3 (2)

22.5 (21)

23. 0 (21)

l.3
0.4
1.0
2.0
1.3

(1)

(O}

(2)
(2)

PEPTIDE 50-62

0.8
0.8
1.0
0.1
0.9
0.8
0.4
1.6

(1)
(1)
(1)

(0)

(1)
(1)

(0)

(2)
1.0 (1)

0.5
1.1
0.8
0.4

(0)
(1)
(1)

(0)

1. 2 (2)

0.5 (0)

1.2 (1)

12.3 (13)

aTrypsin and CNBr digests were hydrolyzed in 6 N HC1 at 110 C in
vacuo for 24 hr and resolved by ion exchange chromatography on
Bio-Rad AG 50W-X2 resin according to the method of Spackman,
et al. (21).
bGel permeation chromatography was done using Sephadex G-50 and
G-25 superfine with 9% formic acid as solvent.
clon exchange chromatography on resin cited in a, with e1uent
pyridine-acetate buffer (19).
dCysteine was detected as pyridylethyl cysteine.
eNot determined.
f Methionine was detected as homoserine lactone in analysis of
peptide 50-62.
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-region beginning with cysteine at position 50 was sequenced cleanly
through methionine 62 (Table I).

These data unequivocally positioned

glutamic acid at residue 58, followed by glutamine at 59. Although the
sequence of 50-113 answered the original question of position 58 identity,
subsequent digestions were initiated to yield a·shorter peptide for both
amino acid composition and sequence determination.
PEPTIDE 50-62
Peptide 50-113 was reacted with CNBr and the cleavage products
were resolved by gel permeation chromatography into a series of peaks
shown in Figure 4. The peak eluting at 0.62 VT was tentatively assigned
to contain CNBr peptide 50-62 on the basis of high 260 nm and low 280 nm
absorbances, expected from the presence of PE-cysteine (16) and the
absence of tyrosine and tryptophan.

Fractions from this peak were

pooled, lyophilized and subjected to amino acid sequence determination.
Sequenator analysis (Table I) showed that peptide 50-62 was the major
component and verified the expected sequence of 12 amino acids beginning
with cysteine and ending with the penultimate amino acid, leucine.
Glutamic acid was again clearly identified as residue 58 followed by
glutamine at 59 (Fig. 5 and 6).

The only contaminating peptide apparent

in the sequencing was peptide 49-62, arising from incomplete trypsin
cleavage between arginine 49 and cysteine 50. This caused a greater
amount of carry-over in each sequence cycle than is normally observed.
A sample of CNBr peptide 50-62 was subjected to amino acid analysis
(Table II).

This material was prepared by reduction of peptide 50-113

prior to CNBr treatment.

The amino acid analysis corroborated the sequence
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Figure 4. Gel permeation chromatography of CNBr digestion
products (16 mg) of peptide 50-113 on Sephadex G-50 superfine.
Conaitions as described in Figure 2.
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CYCLE 9, GLU

(A)

~

t
t

l

ASN GLU
Figure Sa. Gas-liquid chromatography of PTH-derivative from
sequenator analysis of peptide 50-62. (A) Glutamic·acid is
the cycle 9 (residue 58) amino acid. Small carry-over from
cycles 7 (LEU) and 8 (ASN) are present.
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CYCLE 10, GLN

(B)

LEU

ASN GLN

Figure Sb. Gas-liquid chromatography of PTH-derivative from
sequenator analysis of peptide 50-62. (B) Glutamine is the
cycle 10 (residue 59) amino acid. Intensity of the g1utamic
acid is characteristic of glutamine: Diminished LEU and ASN
carry-over are noted.
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CYCL!9

CYCLE 10

.... "'"'
:I

2

IO

4

Figure 6. High-performance-liquid chromatograms of PTHderivatives from sequenator analysis of peptide 50-62.
Cycle 9 (residue 58) shows glutamic acid as the new peak.
Overlap of Leu and Asn from cycles 7 and 8, re?pectively, are
present. Cycle 10 (residue 59) shows a new peak which
corresponds to glutamine. Leu and Asn carry-over is noticed
altho~gh the Leu intensity is diminished.
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obtained for CNBr peptide 50-62.

However, serine, a1anine, isoleucine

and tyrosine occurred to the extent of 0.4-0.5 residue when none was
anticipated.

Thus, some other peptide material must be present, although

at too low a level to appear in the sequenator analysis.

The COOH-

terminus of peptide 50-62, methionine, was modified in the CNBr reaction
to homoserine lactone which is in equilibrium with homoserine.

Acid

hydrolysis converted all homoserine to the lactone (13) allowing indirect
methionine quantitation by amino acid analysis.
The eultion profile of the CNBr hydrolysate (Fig. 4) contained a
minimum of three earlier eluting peaks other than the one assigned to
peptide 50-62.

The majority of this material is probably the other

cleavage product, peptide 63-113, in various states of aggregation.
However, unreacted starting material may also be present.

PEPTIDE 54-74
Trypsin digestion of peptide 50-113 cleaved at lysyl residues
produces a number of smaller fragments which could be partially resolved
on a Sephadex G-50 superfine column (Fig. 7).

The shoulder at 0.69 VT

was tentatively identified as containing peptide 54-74 on the basis of
its tyrosine-like ultraviolet spectrum.

This spectrum is compared to

the spectrum of the tryptophan rich starting material and model compounds
(Fig. 8,9).

Fractions exhibiting the tyrosine-rich spectrum were pooled,

lyophilized and rechromatographed on a Sephadex G-25 superfine column
(Fig. 10).

The material eluting at 0.44 VT was subjected to amino acid

analysis (Table II).

Comparison of the experimental versus expected

amino acid composition indicated considerable contamination.

The remaining
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figure 7. Gel permeation chromatography of trypsin digestion
products of peptide 50-113 (48 mg) on Sephadex superfine.
Conditions as described in Figure 2.
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Figure 8. Ultraviolet spectra of t. touldii hemerythrin
peptide 50-.J.13 (A)· and peptide 54-74 B).
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Figure 10. Gel permeation chromatography of peptide 54-74 (5 mg)
on Sephadex G-25 superfine. Conditions as tlescribed in Figure 2.
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fractions were pooled and chromatographed on an AG 50W-X2 ion

e~change

column. This significantly improved the.peptide purity as evidenced by
an amino acid analysis more consistent with the theoretical (Table II).
However, fractional residues of threonine, lysine, and glycine persisted,
suggesting incomplete trypsin cleavage at lysine 53, such that a significant amount of peptide 50-74 remained in the sample.

Subsequently,

trypsin cleavage was enhanced by inclusion of 2 Murea in the digestion
reaction.

However, the resulting product, peptide 54-74, had reduced

solubility in pyridine-acetate buffer and precipitated during the ion
exchange purification.

Thus, the insolubility of peptide 54-74 precluded

its use in amino acid sequence determination.

DISCUSSION
Trypsin

d~gestion

off_. gouldii citraconylated hemerythrin followed

by gel permeation chromatography yielded peptide 50-113 in sufficient
quantity and purity for sequenator analysis.

The peptide's NH 2-terminus
was cysteine and the amino acid identities were sequentially determined
as indicated in Table I through methionine at position 62.

This sequence

clearly identified position 58 as glutamic acid. Of importance was
verification of methionine-62 since its presence allowed an alternative
specific cleavage procedure of peptide 50-113 with CNBr.

Since an amino

acid sequence determination corroborated by an amino acid composition is
accepted as being reliable, formation and isolation of peptide 50-62 was
pursued using CNBr cleavage and gel permeation chromatography.
Digestion of tryptic peptide 50-113 with CNBr yielded cleavage
products, peptides 50-62 and 63-113.

No detectable advantage was obtained

from prior mercaptoethanol reduction of peptide 50-113, indicating a low
occurrence of methionine sulfone and sulfoxide residues.

Sequenator

analysis on the fractions pooled and lyophilized from the 0.62 VT peak
of Figure 4 unequivocally assigned glutamic acid and glutamine to
positions 58 and 59, respectively, terminating with the penultimate
residue at 61, leucine. This sequence is corroborated by amino acid
analysis which is in good agreement with the expected composition for
peptide 50-62.
Purity of peptides 50-113 and 50-62 is evidenced by lack of extraneous amino acid peaks in the detection chromatograms, indicating
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effective cleavage by trypsin and CNBr, respectively, as well as reliable
chromatographic resolution of the hydrolysates with Sephadex G-50 superfine.
Attempts at purification and sequence determination of peptide 54-74
from trypsin digestion of peptide 50-113 were abandoned when the peptide
precipitated in the pH 3.1 pyridine-acetate ion exchange chromatography
buffer and. failed to elute from the column.

Apparently, the peptide's

high percentage of hydrophobic residues (57%) confers a peptide conformation unfavorable to dissolution in the polar solvent.

The peptide

would be even less soluble at pH 5, the pH required to elute the peptide
from the negatively charged column, since it is essentially isoelectric
at this pH.
The amino acid sequence determinations of peptides 50-113 and 50-62
unambiguously identified glutamic acid at position 58 followed by glutamine
at 59 in f_. gouldii hemerythrin.

Use of sequenator analysis coupled with

direct asparagine and glutamine identification strongly suggests that the
proposed sequence is correct. The high reliability of our sequencing
method resides in precise regulation of temperature, reagents and pressure
at each step of a cycle, enhanced extraction of the thiazolinone intermediate and sensitive detection of the PTH-amino acid derivative by gas1iquid (22) and high-performance-liquid chromatography (23).

The greater

than .95% recovery which is generally achieved in each derivatization,
cleavage and detection cycle minimizes overlap from adjacent residues,
making it possible to sequence 30-50 residues of a peptide at a time (22).
The early position of glutamic acid 58 and glutamic 59 within the first
10 residues of the peptides which we sequenced lends further credibility

to our identification.
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The earlier p_. gouldii hemerythrin sequence which reported the
reverse order of glutamic acid and glutamine at positions 58 and 59
utilized a manual Edman degradation in conjunction with older detection
procedures (12}.

Peptide 56-61, whose partial sequence was previously

reported (18}, was shown to contain 2 of the 3 acidic residues (asp,
g1u 2) in the amidated form on leucine aminopeptidase digestion.

The

manual Edman degradation of peptide 56-61 yielded the sequence, Leu-AspGlu-Glu, according to the amino acid analysis from each cycle following
alkaline regeneration.

Since the amide group is hydrolyzed under alkaline

conditions, methods that preserve the amides' chemical integrity were
adopted to determine the presence of glutamine in this region.

Peptide

56-61, generated by chymotrypsin digestion of peptide 50-113, was subjected
to carboxypeptidase A cleavage.

This exopeptidase lacks high specificity

as indicated in Table III and cleaves from the COCH-terminal until stopped
by praline or arginine.

Glutamic acid is very slowly released by this

exopeptidase whereas, glutamine is rapidly cleaved.

Assignment of position

59 as glutamic acid (and by inference position 58 as glutamine) resulted
from the slow appearance of glutamic acid and no glutamine on carboxypeptidase A cleavage.

More exact kinetic information concerning the rate

of glutamic acid release was not included in the sequence report.
The failure of Subramanian and coworkers to observe the release of
glutamine after treatment could have been due to experimental difficulties
and should not be considered as definitive evidence for the presence of
glutamic acid at position 59.

The more direct and positive identification

of glutamic acid at position 58 and glutamine at position 59 by gas-liquid
and high-performance-liquid chromatography in the present investigation
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TABLE III
RATES OF HYDROLYSIS OF PEPTIDE SUBSTRATES
BY CARBOXYPEPTIDASE Aa
VERY'SLOWc
Tyr
Phe
Trp
Leu
Ile

Met
Thr
Gln
His
Ala
Val

Asn
Ser
Lysb

Gly
Asp
Glu
CyS03H
S-carboxymethyl
Cys

NOT RELEASEDc
Pro
Arg

aAdapted from R. P. Ambler, Methods Enzymol., 25,
262 (1972). Reported by Light (29).
bThe rate of release of lysine may be influenced by
the pH of the hydrolysis mixture.
cThe presence of a "very slow" or "not released" amino
acid as penultimate residue will generally decrease
the rate of release of the COOH-terminal amino acid.
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indicates that the previous1y reported order must have been in error. The presence of glutamic acid at position 58 off.. gouldii
hemerythrin supports the Stenkamp, Sieker and Jensen model (3) for the active
site of hemerythrin because it shows complete conservation of the amino
acids proposed as iron ligands in the three proteins which have been completely sequenced.

The identification of glutamic acid as an iron 1igand

is chemically sensible as the deprotonated carboxyl group at neutral pH
is capable of electron density donation to the electrophilic iron.

Know-

ledge of the iron environment in hemerythrin is important as a potential
model for oxygen-activating enzymes as well as for industrial development
or modification to a useful synthetic catalyst.

CONCLUSIONS
Knowledge derived from the Stenkamp, Stieker and Jensen active site
model of T. dyscritum hemerythrin has potentially diverse applications.
Identification of the iron ligand at position 58 as glutamic acid in

t·

gouldii hemerythrin is, therefore, significant in the support it lends

to the Stenkamp model.
Atkins, et al. (24) reported spectral and magnetic similarities
between hemerythrin's active center and the iron-containing catalytic center
of ribonucleotide reductase.

Use of hemerythrin as a model system may be

helpful in elucidating the catalytic mechanism of the reductase whose
biochemical function is reduction of ribonucleotides to their deoxy form.
Ribonucleotide reductase is a strategic regulatory point in DNA synthesis
and is under fine feedback control of substrates -and allosteric effectors.
Agents capable of reductase inhibition are actively sought for their chemotherapeutic value.

The most effective inhibitory drugs tested in vitro

have been strong iron chelators, i.e., thiosemicarbazones of 1-formylisoquinoline and 2-formylpyrdine, (25) which would likely interfere with
general iron metabolism in vivo.

Structural information obtaineq from

hemerythrin's iron active site in conjunction with the reductase's known
substrate affinity has the potential for yielding a highly specific anticancer drug.
Use of hemerythrin synthetic analogs may improve the performance and
longevity of artificial respirators.

Currently, a synthetic analog of

hemoglobin, Collman's tetraphenyl porphyrin picket fence (26), is utilized
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in respirators but a high affinity for CO leads to poisoning of the analog.
Since hemerythrin has little affinity for CO, an analog of structural
design similar to the protein's active site would be medically beneficial.
Chemical models of oxygen activating proteins are indus.trially
desirable as catalysts capable of high specificity under mild conditions
(27).

Elucidation of the complex principles underlying oxygen activation

is a prerequisite for development of a suitable catalyst.

This achievement

will be possible only through the concerted efforts among the diverse
branches of chemistry.

An alternative to the development of synthetic

catalysts capable of oxygen activation is modification of the protein
allowing imnobilization on a solid support.

Ideally, such a system would

be amenable to stereoselectivity and large-scale operation.

. ·· 1 .

REFERENCES
1.

Okamura, M. Y., and Klotz, I. M. (1973) Inorganic Biochem, l' 320.

2. Ward, K. B., Hendrickson, W. A., and K1ippenstein, G. L. (1975)
Nature (London), 257, 818.
3. Stenkamp, R. E., Sieker, L. C., and Jensen, L. H. (1976) Proc. Natl.
Acad. Sci. USA, 73, 349
4.

Loehr, T. M., Dunn, J.B. R., and Loehr, J. S. (1976), Handbook
of Biochemistry and Molecular Biology, 3rd Ed., 1, 588.

5.

Loehr, J. S., Lammers, P. J., Brimhall, B., and Hermodson, M.A.,
(1978) J. Biol. Chem., in press.

6.

Hendrickson, W. A. (1978) Naval Research News,

.

7.

~'

1

Klippenstein, G. L., Cote, J. L., and Ludlam, S. E. (1976)
Biochemistry, 15, 1128.
'

8. Subramanian, A. R., Holleman, J. W., and Klotz, I. M. (1968)
Biochemistry, ]_, 3859.
9.

Edman, P. and Begg, G. (1967) European J. Biochem., l, 80.

10.

Canfield, R. E., and Anfinsen, C. B. (1963) Proteins, l, 311.

11.

Hermodson, M.A., Ericsson, L. H., Neurath, H., and Walsh, K. A.
(1073) Biochemistry, lf., 3146.

12.

Klippenstein, G. L., Holleman, J. W., and Klotz, I. M. (1968)
Biochemistry, ]_, 3868.

13.

Gross, E. (1967) Methods Enzymol., ]J_, 238.

14.

Weihing, R. R., and Korn, E. D. (1972) Biochemistry, Jj_, 1539.

15.

Klotz, I. M., Klotz, T. A., and Feiss, H. A. (1957) Arch. Biochem.
Biophys. , 68, 284.

16.

Friedman, M., and Krull, L. H. (1969) Biochem. Biophys. Res.
Commun., 37, 630.

17. Atassi, M. Z., and Habeeb, A. F. S. A. (1972) Methods Enzymol.,
fi, 546.

38
18. Groskopf, W.R., Holleman, J. W., Margoliash, E., and Klotz, I. M.
(1966) Biochemistry, .§_, 3779.
19. Jones, R. T. (1970) Methods'Biochem. Anal., 1§., 205.
20.

West, R. (1965) J. Chem. Educ., 42, 386.

21.

Spackman, D. H., Stein, W. H., and Moore, S. (1958) Anal. Chem.,
30, 1190.

22.

Hermodson, M.A., Ericsson, L. H., Titani, K., Neurath, H., and
Walsh, K. A. (1972) Biochemistry, }l, 4493.

23.

Zimmerman, C. L., Apella, E., and Pisano, J. J. (1977) Analyt.
Biochem., 77, 569.

24.

Atkins, C. L., Thelander, L., Reichard, P., and Lang, G. (1973)
J. Biol. Chem., 248, 7464.

25.

Hogenkamp, H.P. C., and Sando, G. N. (1974) Struct. and Bond.,
20' 23.

26.

Collman, J.P., and Reed, C. A. J. (1973) Amer. Chem. Soc., 95,
2048.

27.

Sheldon, R. A., and Kechi, J. K. (1976) Adv. in Catal., 25, 272.

28.

Weinheim, and Butterworths (1966) OMS UV Atlas of Organic Compounds,
f., Jl/l and Jl/3.

29.

Light, A. (1974) Proteins:
Inc., N. J., 119.

30.

Hendrickson, W. A., Klippenstein, G. L., and Ward, K. B. (1975)
Proc. Natl. Acad. Sci. USA, 72, 2160.

31.

Dunn, J.

32.

Breslow, E. (1973) in Inorganic Biochemistry, Eichhorn, G. L., Ed.,
New York, N.Y., Elsevier, 227.

.Ii,

Structure and Function, Prentice-Hall,

R., Shriver, D. F., and Klotz, I. M. (1975) Biochemistry,
2689.

B~

